ClinicalTrials.govpublic full text
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
lung neoplasm, carcinoma non-small cell lung cancer stage iiia, carcinoma non-small cell lung cancer stage iiib, carcinoma non-small cell lung cancer stage iv, gene therapy, flow cytometry, immunoenzyme technique, laboratory biomarker analysis, quality-of-life-assessment, tumor cell-derivative vaccine therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010931
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.